Intrinsic Value of S&P & Nasdaq Contact Us

Tilray Brands, Inc. TLRY NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
47/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$10.00
+44.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Tilray Brands, Inc. (TLRY) has a negative trailing P/E of -0.4, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 241.6 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -249.75%, forward earnings yield 0.41%. PEG 0.70 (Peter Lynch undervalued ≤1.0).

Criteria proven by this page:

  • VALUE (96/100, Pass) — PEG ≤ 1.0 — Peter Lynch undervalued (0.70); analyst target implies upside (+44.7%).
  • Forward P/E 241.6 — analysts expect a return to profitability with estimated EPS of $0.03 for FY2028.
  • PEG Ratio 0.70 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield -249.75% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 0.41% as earnings recover.
  • Analyst consensus target $10.00 (+44.7% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 47/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
VALUE
96/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
52/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
47/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — TLRY

Valuation Multiples
P/E (TTM)-0.4
Forward P/E241.6
PEG Ratio0.70
Forward PEG0.70
P/B Ratio0.47
P/S Ratio0.65
EV/EBITDA-0.5
Per Share Data
EPS (TTM)$-16.38
Forward EPS (Est.)$0.03
Book Value / Share$13.54
Revenue / Share$10.49
FCF / Share$-0.85
Yields & Fair Value
Earnings Yield-249.75%
Forward Earnings Yield0.41%
Dividend Yield0.00%
Analyst Target$10.00 (+44.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 4,705.6 0.00 53.48 222.04 -
2017 848.2 0.00 773.89 174.21 -
2018 171.4 0.00 -634.72 136.75 -
2019 -417.5 0.00 38.84 58.29 -
2020 -30.8 0.00 8.30 7.78 -
2021 -10.3 0.00 1.03 7.39 -
2022 -3.6 0.13 0.39 2.73 -
2023 -0.5 0.00 0.23 1.22 -
2024 -4.0 0.05 0.28 1.24 -
2025 -0.1 0.00 0.18 0.34 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.01 $6.47M $305.12K 4.7%
2017 $0.04 $15.17M $3.12M 20.5%
2018 $0.16 $28.63M $22.84M 79.8%
2019 $-0.06 $175.25M $-12.19M -7%
2020 $-0.61 $391M $-61.02M -15.6%
2021 $-1.25 $513.09M $-336.01M -65.5%
2022 $-0.90 $628.37M $-434.13M -69.1%
2023 $-2.34 $627.12M $-1.44B -230.1%
2024 $-0.33 $788.94M $-244.98M -31.1%
2025 $-33.80 $1.13B $-3B -266.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.48 $-0.61 – $-0.33 $864.39M $853.4M – $881.89M 3
2027 $-0.27 $-0.50 – $-0.10 $923.3M $865.05M – $1.06B 4
2028 $-0.05 $-0.05 – $-0.05 $983.83M $918.04M – $1.05B 3
2029 $0.22 $0.20 – $0.24 $1.08B $1.01B – $1.15B 2
2030 $0.36 $0.32 – $0.39 $1.12B $1.04B – $1.2B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message